Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial citric acid cycle** (also known as the Krebs cycle or tricarboxylic acid (TCA) cycle) is a core metabolic pathway in bacteria that oxidizes acetyl-CoA to carbon dioxide, producing energy in the form of ATP, and generating NADH and FADH₂ for cell respiration[1][3][5][6][8]. In bacteria, the cycle occurs in the cytosol and is essential for energy production and biosynthesis of key intermediates. Variations and regulatory alterations of this pathway play a significant role in bacterial physiology, including the development of metabolic-based antibiotic tolerance[2][4][10]. The pathway itself is too broad to be considered a conventional drug target; however, individual enzymes within the pathway (such as isocitrate dehydrogenase, citrate synthase, etc.) have been studied as potential antimicrobial targets.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial citric acid cycle (TCA cycle (bacterial)).